Pegylated Liposomal Doxorubicin (Caelyx(R)) as Monotherapy in Elderly Patients With Locally Advanced and/or Metastatic Breast Cancer (Study P05059)

Clinical trial NCT00604968 · TERMINATED

Trial details

NCT number: NCT00604968
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2007-02-07
Primary completion: 2009-10-16
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.